Trials / Completed
CompletedNCT02567747
Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age
Impact of Vaccination Against Pneumococcal Disease on the Morbidity of Acute Otitis Media in Colombian Children < 5 Years of Age
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 59 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to provide data on trends of morbidity due to Acute Otitis Media (AOM) (primary analysis) and morbidity and mortality due to pneumonia, and AOM related health care resources before and after the introduction of vaccination against pneumococcal disease within the Universal Mass Vaccination (UMV) in Colombia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | Data will be collected retrospectively for cases identified through RIPS\*/ DANE\*\* from 2008 until 2014 and through PAI\*\*\* from 2009 until 2014. \*Registro Individual de Prestación de Servicios de Salud (RIPS) database (Health Service Provider Individual Registration Database), Columbia. \*\*Departamento Administrativo Nacional de Estadística (DANE) database (The National Administrative Department of Statistics database), Columbia. \*\*\*Programa Ampliado de Immunizaciones (PAI) database (National Immunization Program database), Columbia. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-23
- First posted
- 2015-10-05
- Last updated
- 2019-06-10
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT02567747. Inclusion in this directory is not an endorsement.